(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 82.6MM | +13% |
Operating Income | -102.9MM | - |
Operating Expenses | 185.5MM | - |
Net Income | -100.8MM | - |
R&D | 12.5MM | +1% |
G&A | 13.9MM | -11% |
Marketing | 14.1MM | -0% |
Amortization | 6.7MM | +12% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on A
News of a fresh round of financing made many investors rather unhappy.
ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks’ digital channels, today announced its intention to offer, subject to market and other conditions, $150.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cardlytics also expects to grant the
Activists report to the SEC on New York Community Bancorp, Cardlytics, ANI Pharmaceuticals, Vista Outdoor, and Bristow Group.
Shareholders will be ecstatic, with their stake up 71% over the past week following Cardlytics, Inc. 's ( NASDAQ:CDLX...
While Cardlytics, Inc. ( NASDAQ:CDLX ) might not have the largest market cap around , it saw a significant share price...
Cardlytics ( NASDAQ:CDLX ) Full Year 2023 Results Key Financial Results Revenue: US$309.2m (up 3.6% from FY 2022). Net...
Cardlytics, Inc. (NASDAQ:CDLX) Q4 2023 Earnings Call Transcript March 14, 2024 Cardlytics, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $0.12. CDLX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
Wall Street is surprised to watch this company come to life after it was left for dead.
Q4 2023 Cardlytics Inc Earnings Call